A*STAR Genome Institute of Singapore (A*STAR GIS)

Using a new genome analysis technology, A*STAR scientists discover never-before-seen immune responses in tuberculosis infections.

Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.

Through innovative molecular technologies, Jinyue Liu is building maps of the brain’s circuitry to better understand how these connections go awry in disease.

To meet Singapore’s goal of sustainable food production, the trio behind the A*STAR spinoff Meatiply reveals their journey in building the company and developing alternative proteins.

Experimental gene therapy promises a new lease of life for patients with genetic heart disease.

New gastric cancer insights come to light with the help of powerful single-cell technologies.

Cancer genetics experts say new technologies and more comprehensive data collection are required to deepen our understanding of tumour lifecycles.

By looking at Peranakan Chinese genomes, researchers confirm the community arose from genetic mixing between local Malay women and foreign Chinese traders in the past.

Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.

Understanding the mechanisms behind RNA structure and folding could pave the way for more effective medical treatments, say Yue Wan and Ashley Aw.

Ushering in an era of targeted precision medicine, scientists across A*STAR are propelling the research, commercialisation and implementation of RNA-based therapeutics.

The first open-access database of mononuclear phagocytes, created by A*STAR researchers, provides insight into the biology of these immune cells and their roles in fighting disease.